SenesTech (NASDAQ:SNES) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES) in a research report issued on Sunday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright restated a “buy” rating and issued a $3.50 price objective on shares of SenesTech in a research note on Tuesday, May 14th.

SenesTech Trading Up 1.4 %

Shares of SNES stock opened at $0.76 on Friday. The company has a current ratio of 6.91, a quick ratio of 5.69 and a debt-to-equity ratio of 0.03. The firm has a 50-day moving average of $0.74 and a 200-day moving average of $0.93. SenesTech has a one year low of $0.52 and a one year high of $16.56.

SenesTech (NASDAQ:SNES) last posted its quarterly earnings data on Thursday, May 9th. The company reported ($0.36) EPS for the quarter, missing the consensus estimate of ($0.34) by ($0.02). SenesTech had a negative net margin of 545.82% and a negative return on equity of 181.46%. The firm had revenue of $0.42 million during the quarter, compared to analysts’ expectations of $0.43 million. During the same quarter last year, the business posted ($15.85) EPS. On average, equities research analysts anticipate that SenesTech will post -1.1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in SenesTech stock. McAdam LLC acquired a new stake in SenesTech, Inc. (NASDAQ:SNES) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned about 1.25% of SenesTech at the end of the most recent quarter. 5.19% of the stock is owned by institutional investors.

SenesTech Company Profile

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.